换一批Cancer Care Coordinators to Improve Tamoxifen Persistence in Breast Cancer: How Heterogeneity in Baseline Prognosis Impacts on Cost-Effectiveness.
第一作者：
Nisha,Nair
第一单位：
Burden of Disease Epidemiology, Equity and Cost-Effectiveness Programme, Department of Public Health, University of Otago Wellington, Wellington, New Zealand. Electronic address: nisha.nair@otago.ac.nz.
作者：
医学主题词
抗肿瘤药, 激素(Antineoplastic Agents, Hormonal);乳腺肿瘤(Breast Neoplasms);费用效益分析(Cost-Benefit Analysis);女(雌)性(Female);卫生经费支出(Health Expenditures);人类(Humans);Markov链(Markov Chains);服药依从性(Medication Adherence);模型, 经济计量学(Models, Econometric);肿瘤转移(Neoplasm Metastasis);新西兰(New Zealand);预后(Prognosis);质量校正寿命(Quality-Adjusted Life Years);受体, 孕酮(Receptors, Progesterone);他莫昔芬(Tamoxifen)
DOI
10.1016/j.jval.2016.05.015
PMID
27987643
发布时间
2017-05-17
- 浏览84
Value in health
936-944页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
